Evrys Bio Awarded $34 Million from Department of Defense
DOYLESTOWN, PA — Evrys Bio has been awarded a $34.3 million contract from the Department of Defense (DOD) to develop a drug, simultaneously effective against multiple high-risk viral agents.
Read More